Sisram Medical Ltd. announce that the Company has entered into a strategic partnership with Prollenium to expand its injectables product portfolio and offer a unique combination of high-quality dermal filler with energy-based devices to enhance the effectiveness and longevity of various common aesthetic indications. As part of the partnership arrangement, the Company will have exclusive distribution rights for the renowned Revanesse dermal filler collection in several key markets including Germany, Austria, Switzerland, Australia, and New Zealand. Revanesse, Prollenium's flagship product collection, consists of multipurpose dermal fillers that utilize advanced hyaluronic acid technology. These fillers are designed to restore volume, smooth wrinkles, correct and contour facial features. The Company believes that the strategic partnership with Prollenium will strengthen the Company's leadership in the non-invasive and minimally invasive medical aesthetic segment and empower the Company to pioneer cutting-edge solutions by combining advanced injectable
products, which will improve the consumables revenue of the Company in the long term.